August 23, 2013 at 18:14 PM EDT
Celgene On Track To Achieve Aggressive 2017 Sales Goal
When companies get bigger and bigger, it's hard to maintain double-digit earning and sales growth rates. But don't tell that to biotech Celgene. (CELG) With a market capitalization approaching $57 billion, Celgene sports a five-year earnings growth rate of 34% and a sales growth rate of 27%. If that weren't enough, in 2012
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here